Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (2) , 112-118
- https://doi.org/10.1053/rmed.1999.0618
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmaticsEuropean Respiratory Journal, 1996
- Challenge Tests to Assess Airway Hyperresponsiveness and Efficacy of Drugs Used in the Treatment of AsthmaJournal of Aerosol Medicine, 1996
- Management of Asthma with ZafirlukastDrugs, 1996
- Clinical value of monitoring eosinophil activity in asthma.Archives of Disease in Childhood, 1995
- Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.Thorax, 1995
- Leukotriene receptor antagonists and biosynthesis inhibitors: potential breakthrough in asthma therapyEuropean Respiratory Journal, 1995
- Airway hyperresponsiveness: relation to asthma and inflammation?Thorax, 1993
- Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.Archives of Disease in Childhood, 1993
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.Thorax, 1984